Linden Asset
Shanghai, Shanghailindenasset.com
Overview
Venture capital firm that focuses on growth-stage and Series B startups in the Asia Pacific region, particularly in the fields of biotechnology, medtech, high tech, and smart technology. It manages both US dollar- and RMB-denominated funds. As of December 2020, the firm had invested in 12 companies. Its portfolio includes companies that have had IPOs, such as Shanghai Henlius Biotech, PPDai, and Genor Biopharma.
Portfolio Companies
4
Website
lindenasset.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pulse Medical Imaging Technology | Aug 2021 | Series C | Co-investor |
| Creative Biosciences (Guangzhou) Co., Ltd. | Sep 2020 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
